Stephane Bancel
CIK 1443340 · Chief Executive Officer · last filed 2026-03-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$783.21M
Companies
5
Total Filings
299
Lifetime Open-Market Net
-$1.19B
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MRNA | Chief Executive Officer | 15,398,477 | $49.91 | $768.54M | -$1.19B | 284 | 2026-03-03 |
| GENB | Director | 1,184,989 | $12.38 | $14.67M | $0 | 1 | 2026-03-02 |
| SYRS | Director | 47,980 | $0.00 | $19 | $0 | 2 | 2016-09-19 |
| BG Medicine, Inc. (BGMD) Delisted | Executive Chairman | 123,167 | — | — | $226.1K | 11 | 2013-11-04 |
| Targanta Therapeutics Corp. (TARG) Delisted | Director | — | — | — | $0 | 1 | 2008-08-26 |
Recent Filings · Page 3 of 30
299 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-04-28 | MRNA | Mixed | — | -$10.41M | EDGAR |
| 2023-04-21 | MRNA | Mixed | — | -$11.36M | EDGAR |
| 2023-04-14 | MRNA | Mixed | — | -$12.62M | EDGAR |
| 2023-04-07 | MRNA | Mixed | — | -$12.41M | EDGAR |
| 2023-03-31 | MRNA | Mixed | — | -$11.80M | EDGAR |
| 2023-03-24 | MRNA | Mixed | — | -$11.90M | EDGAR |
| 2023-03-17 | MRNA | Mixed | — | -$11.91M | EDGAR |
| 2023-03-10 | MRNA | Mixed | — | -$11.14M | EDGAR |
| 2023-03-03 | MRNA | Mixed | — | -$10.83M | EDGAR |
| 2023-03-02 | MRNA | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.